MENU
BLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioLineRx (BLRX) Earnings Date & Reports
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
BLRX is expected to report earnings to fall 50.65% to -37 cents per share on November 23
Q3'26
Est.
$-0.38
Q2'26
Missed
by $0.77
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.14
Q1'24
Beat
by $0.16
The last earnings report on August 31 showed earnings per share of -76 cents, missing the estimate of 0 cents. With 2.94K shares outstanding, the current market capitalization sits at 10.11M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical development company
Industry Biotechnology
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
24
Web
https://www.biolinerx.com